3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
18
Lymphoma
12
Lymphoma, Non-Hodgkin
11
Lymphoma, Follicular
10
Lymphoma, Mantle-Cell
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Hairy Cell
4
Burkitt Lymphoma
4
Recurrence
3
Neoplasms
3
Lymphoma, B-Cell
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoproliferative Disorders
2
Infections
2
Epstein-Barr Virus Infections
2
beta-Thalassemia
1
Thalassemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphatic Diseases
1
Lymphadenopathy
1
Leukemia, Prolymphocytic
1
Interventions
ruxolitinib
3
Cyclophosphamide
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Cyclosporine
2
umbralisib
1
itacitinib
1
iadademstat
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Specimen Handling
1
Sirolimus
1
Panobinostat
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
INCB039110
1
Hyperbaric Oxygenation
1
Etoposide
1
CPI-0610
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Rituximab
×
30 days
×
Clear all
No trials found.